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Pericytes are multi-functional cells embedded within the walls of capillaries throughout
the body, including the brain. Pericytes were first identified in the 1870s, but little
attention was paid to them during the following century. More recently, numerous
vascular functions of pericytes have been identified including regulation of cerebral blood
flow, maintenance of the blood-brain barrier (BBB), and control of vascular development
and angiogenesis. Pericytes can also facilitate neuroinflammatory processes and
possess stem cell-like properties. Pericytes form part of the neurovascular unit (NVU), a
collection of cells that control interactions between neurons and the cerebral vasculature
to meet the energy demands of the brain. Pericyte structure, expression profile,
and function in the brain differ depending on their location along the vascular bed.
Until recently, it has been difficult to accurately define the sub-types of pericytes, or
to specifically target pericytes with pharmaceutical agents, but emerging techniques
both in vitro and in vivo will improve investigation of pericytes and allow for the
identification of their possible roles in diseases. Pericyte dysfunction is increasingly
recognized as a contributor to the progression of vascular diseases such as stroke and
neurodegenerative diseases such as Alzheimer’s disease. The therapeutic potential of
pericytes to repair cerebral blood vessels and promote angiogenesis due to their ability
to behave like stem cells has recently been brought to light. Here, we review the history
of pericyte research, the present techniques used to study pericytes in the brain, and
current research advancements to characterize and therapeutically target pericytes in
the future.
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protein 1 receptor; MMP9, matrix metalloprotease 9; NG2, neural/glial antigen 2; NOTCH, neurogenic locus notch homolog
protein; NVU, neurovascular unit; PDGF-BB, platelet-derived growth factor-BB; PDGFR-β, platelet-derived growth factor
receptor beta; TGF-β, transforming growth factor beta; TNF-α, tumor necrosis factor alpha; VEGF, vascular endothelial
growth factor; VSMC, vascular smooth muscle cell.
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HISTORY OF PERICYTE RESEARCH
Pericytes were first identified in the late 19th century by Eberth,
then Rouget, as spatially isolated cells associated with the capillary
wall (Attwell et al., 2016). They were found embedded within
the basement membrane, both on straight sections and at branch
points of capillaries, with projections extending from the soma
to wrap around the underlying vessel. In the 1920s, Zimmerman
named these cells pericytes, stating that he included various cell
morphologies under the definition of pericyte, including their
transitional forms to vascular smooth muscle cells (VSMC) at
the arteriolar end (Zimmermann, 1923). This definition is used
broadly in research investigating pericyte function and has led to
debate over what constitutes a pericyte (Hill et al., 2015; Attwell
et al., 2016). Throughout the 20th century, there was relatively
little research into pericytes. With advancing technologies and
more accurate techniques to identify and study pericytes, research
into pericyte function has increased exponentially over the last
15 years (Figure 1A). Numerous studies have reported novel
functions for pericytes in different organs of the body, including
the heart (Avolio and Madeddu, 2016) and the brain (Sweeney
et al., 2016), with 25% of all papers on pericytes focused on
the brain (Figure 1A). Current research largely focuses on
characterizing pericyte mechanisms of function, defining pericyte
sub-classes (Figure 1B), their roles in health and disease, and
their potential as a therapeutic target to treat disease.
CURRENT STATE OF KNOWLEDGE ON
PERICYTES IN THE BRAIN
Pericytes in the Neurovascular Unit
The brain is one of the most energy-demanding organs in
the body. Despite only accounting for 2% of the body’s mass,
over 20% of cardiac output is distributed to the brain to
meet oxygen and glucose requirements at rest (Xing et al.,
2017). To deliver blood flow to neuronal and glial cells, the
mammalian brain has evolved the neurovascular unit (NVU), a
complex unit of cells that connects the brain parenchyma to the
cerebral vasculature. The NVU consists of brain parenchymal
cells including excitatory neurons, inhibitory interneurons,
astrocytes, and microglia interacting with vascular cells including
pericytes (on capillaries), VSMC (on arterioles and arteries),
and endothelial cells (EC) (McConnell et al., 2017; Figure 2).
The NVU plays important roles in maintaining brain function,
particularly the regulation of cerebral blood flow (CBF) and the
formation of the blood-brain barrier (BBB). Pericytes are central
to NVU function as they are located at the interface between
the brain parenchyma and the blood vessels, and so can act
as chemical sensors to enable communication between the two
groupings of cells.
Functions of Pericytes
Cerebral Blood Flow
The mammalian brain has evolved a mechanism for regional
control of CBF known as neurovascular coupling, which ensures
a rapid increase in the amount of CBF directed to active neurons
FIGURE 1 | (A) Publications found in PubMed with the search term “Pericyte”
or “Pericyte Brain” by year showing a rapid increase in publications in the 21st
century. About 25% of all pericyte papers are focused on the brain.
(B) Overview of main pericyte sub-types, their functions, and roles in disease.
(Attwell et al., 2010). Neurovascular coupling is controlled by the
cells within the NVU, which includes pericytes.
Within the brain, pericytes can actively relax or contract to
change CBF in response to localized changes in neuronal activity
(Hall et al., 2014; Mishra et al., 2016; Kisler et al., 2017b; Cai
et al., 2018). Pericytes possess contractile proteins including
alpha-smooth muscle actin (α-SMA), tropomyosin, and myosin
which give rise to their contractile ability (Rucker et al., 2000;
Alarcon-Martinez et al., 2018). However, it appears that only a
subset of pericytes perform this role, namely the ensheathing
pericytes at the arteriolar end of the capillary bed which express
higher amounts of α-SMA compared to thin-strand pericytes
in the middle and at the venous end of the capillary, though
this remains controversial (Alarcon-Martinez et al., 2018). Still,
it is important to note that red blood cells deform the walls
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FIGURE 2 | The cellular components of the NVU. The capillary wall contains a single EC layer (green) connected by tight junctions that form the blood-brain barrier
along with pericytes (red), that are embedded within the capillary basement membrane (light blue), and nearby astrocyte endfeet (yellow). Excitatory neurons (blue)
synapse with both vasoactive interneurons (purple), and astrocytes (yellow), who in turn signal to the capillary to alter blood flow according to the metabolic
demands of that brain region. Microglia (indigo) are located in the brain parenchyma and respond to any aversive stimuli to protect the brain.
of capillaries when passing through (Jeong et al., 2006), so any
change to tone or rigidity of mid-capillary or venule end pericytes
may also affect CBF by altering the stiffness of the capillary wall,
thereby changing capillary transit time (Attwell et al., 2016).
Vascular Development and Maintenance
Correct development of the cerebral microvasculature is essential
for neuronal function and pericytes play a critical role in
both development and maintenance of cerebral microcirculation.
In adult-viable pericyte-deficient mice, pericyte loss leads to
vascular dysfunction via a reduction in brain microcirculation,
diminished capillary perfusion, loss of blood flow responses
to brain activation, and BBB breakdown associated with brain
accumulation of neurotoxic serum molecules (Bell et al., 2010).
EC use growth factors such as angiopoietin 1, transforming
growth factor beta (TGF-β) and platelet-derived growth factor-
BB (PDGF-BB) to direct pericytes to migrate to new vessels
in order to stabilize the vascular wall (Ribatti et al., 2011). At
the capillary level, pericytes appear to control the cell cycle
of EC, as well as directly contribute to the formation of the
basement membrane (Bergers and Song, 2005). Pericytes also
secrete angiogenic-promoting factors such as vascular endothelial
growth factor and neurogenic locus notch homolog protein
(NOTCH) 3 to activate angiogenic processes in the adult central
nervous system (Ribatti et al., 2011).
The Blood-Brain Barrier
The BBB is a diffusion barrier vital for preventing toxic material
from the circulation entering the brain. Function of the BBB is
reliant on non-fenestrated EC that form the blood vessel wall
and is supported by both pericytes and astrocytes. Pericytes
can modulate and maintain the BBB through the release of
signaling factors to determine the number of EC tight junctions
and direct the polarization of astrocyte endfeet (Armulik et al.,
2010). A reduction in pericyte numbers can cause a loss of tight
junctions between EC, leading to increased BBB permeability
(Sengillo et al., 2013). In addition, pericytes can control the
movement of substances between the blood stream and the brain
parenchyma, including the vascular clearance of toxic species out
of the brain (Ma et al., 2018).
Neuroinflammation
Neuroinflammation is primarily driven by microglia, astrocytes,
and infiltrating leukocytes, though pericytes are also capable
of performing immune cell functions (Jansson et al., 2014).
Pericytes can phagocytose other cells, respond to and express
inflammatory molecules and cytokines, and present antigens to
immune cells (Rustenhoven et al., 2017). Exposure of pericytes to
cytokines such as interleukin-1 beta (IL-1β) and tumor necrosis
factor alpha (TNF-α) triggers the release of inflammatory
molecules and matrix metalloprotease 9 (MMP9), leading to
BBB breakdown (Herland et al., 2016). In addition, it has been
shown that expression of apolipoprotein E, a major genetic
risk factor for Alzheimer’s disease (Kim et al., 2009), or a lack
of murine apolipoprotein E can lead to vascular dysfunction
and BBB breakdown by activating the pro-inflammatory CypA-
nuclear factor-κB-MMP9 pathway in pericytes (Bell et al., 2012).
As a result, pericytes are able to recruit immune cells and
enable their extravasation into the brain (Rustenhoven et al.,
2017). In transgenic pericyte-deficient mice there is reduced
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leukocyte trafficking across the microvasculature, suggesting that
pericytes play a role in leukocyte recruitment into the brain
(Wang et al., 2006).
Stem Cell Potential
Pericytes are often considered to be similar to mesenchymal stem
cells and both in vitro and in vivo studies have shown they
can differentiate into multiple cell types including angioblasts,
neural progenitors, vascular cells, and microglia (Ozen et al.,
2014; Nakagomi et al., 2015). The exact mediators that control
differentiation of pericytes are still under investigation but
pericyte pluripotency can be utilized as a target for therapeutic
intervention for a number of diseases. An interesting example
of pericyte pluripotency is from the dental pulp where pericytes
could be differentiated into both glial and neuronal cell
types (Farahani et al., 2019). However, this example uses
peripheral pericytes and there is increasing evidence at the
single-cell transcriptomic level that there are molecular and
functional differences between brain-derived pericytes and
pericytes residing in the periphery (Vanlandewijck et al., 2018).
Paracrine Interactions of Pericytes
Endothelial cells and pericytes communicate by juxtacrine
and paracrine signaling through mediators such as TGF-β,
angiopoietin 1/2, vascular endothelial growth factor (VEGF), and
PDGF-BB (Sweeney et al., 2016). These factors are important in
directing vessel development and maturation and formation of
the BBB, as well as pericyte survival and contractility (Armulik
et al., 2011). The importance of pericyte-EC interactions can be
seen in pericyte depletion animal models, such as platelet-derived
growth factor receptor beta (PDGFR-β) knockdown mice, that
display abnormal vascular growth and extensive EC apoptosis
(Hellstrom et al., 2001). Pericytes communicate with each other,
allowing the propagation of signals up or down the capillary,
which can assist in the control of blood flow through the capillary
network (Peppiatt et al., 2006). Astrocytes and pericytes can
interact to alter BBB permeability through astrocyte-secreted
apolipoprotein binding to the low density lipoprotein receptor-
related protein 1 receptor (LRP-1) on pericytes (Ma et al., 2018),
and modulate CBF through astrocyte secretion of prostaglandin
E2 binding to pericyte EP4 receptors (Mishra et al., 2016).
Neurons may interact with pericytes through the release of
neurotransmitters to induce pericyte relaxation (glutamate) or
contraction (noradrenaline) thus altering vascular tone (Peppiatt
et al., 2006; Hall et al., 2014). It is also possible that pericytes may
influence neuronal function through the release of neurotrophic
factors (Shimizu et al., 2012). Overall, the interplay between
pericytes and other cell types of the NVU is complex but enables
precise control over CBF and BBB permeability.
PERICYTE DYSFUNCTION IN
NEUROLOGICAL DISEASE
Aberrant pericyte function and/or pericyte deficiency
accompanied by vascular dysfunction has been observed
in several disease states. A recent publication thoroughly
reviews evidence of pericyte dysfunction in a diverse number
of neurological disorders including stroke, AD, glioma and
other tumors, traumatic brain injury, migraine, epilepsy, spinal
cord injury, diabetes, Huntington’s disease, multiple sclerosis,
radiation necrosis, and amyotrophic lateral sclerosis (Cheng
et al., 2018). A short description of pericyte functions in stroke,
AD, and tumor formation is provided below.
Ischemic Stroke
Ischemic stroke involves the disruption of blood supply to the
brain and can cause extensive neuronal death. While reopening
of the blocked artery has been the predominant focus of ischemic
stroke therapy, there has been limited attention given to the
restoration of capillary blood flow. Multiple studies have shown
that following a stroke, pericytes constrict capillaries and die
in rigor causing the capillary to be clamped shut leading to a
long-lasting restriction of blood flow (no-reflow). These changes
to pericytes post-stroke appear to be driven by an influx of
intracellular calcium and oxidative stress (Yemisci et al., 2009;
Hall et al., 2014). In addition, ischemia leads to the release of
MMP9 by pericytes, which interrupts the tight junctions between
EC and the binding of astrocyte endfeet to the vascular wall,
increasing BBB permeability (Underly et al., 2017). Therefore,
pericytes have been identified as an attractive therapeutic target to
prevent ongoing microvascular-mediated restriction of CBF and
opening of the BBB following stroke.
Alzheimer’s Disease
Alzheimer’s disease (AD), a prevalent neurodegenerative
disorder, is characterized by the accumulation of amyloid beta
(Aβ) to form plaques and hyperphosphorylated tau to form
neurofibrillary tangles. However, it is becoming increasingly
recognized that vascular dysfunction through restriction of CBF
and impairment in the BBB could contribute to and even precede
AD onset and progression. It is hypothesized that Aβ may cause
pericyte death, leading to reduced CBF and loss of BBB integrity,
which may in turn accelerate neuronal degeneration and Aβ
plaque build-up (Winkler et al., 2014). In vitro studies have
confirmed Aβ can cause pericyte toxicity (Wilhelmus et al., 2007)
and both rodent and human studies have shown that pericyte loss
occurs in AD (Sagare et al., 2013; Sengillo et al., 2013). Pericytes
can endocytose perivascular debris, giving them a vital role in
the clearance of molecules such as Aβ (Ma et al., 2018) and may
have protective effects in AD. A recent publication demonstrates
that soluble PDGFR-β is a cerebrospinal fluid biomarker of
pericyte injury during early cognitive impairment and correlates
with BBB disruption independent of Aβ and tau (Nation et al.,
2019). Therefore, identifying ways to prevent pericyte loss
in AD is important given that cerebrovascular changes such
as BBB dysfunction and reduced cerebrovascular density can
occur early in the disease. A recent review that focusses on BBB
physiology more comprehensively details pericyte changes in AD
(Sweeney et al., 2019).
Tumor Formation
Tumor development relies on fast and efficient vascularisation
to match growth, but the abnormal branching, disorganized
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networks, uneven basement membranes, and lack of pericytes
favors non-productive angiogenesis and metastasis (Barlow et al.,
2012). Therefore, delivery of pericyte therapy to the tumor
can allow vascular normalization, preventing metastasis and
improving the efficacy of chemo- or radio-therapy (Meng et al.,
2015). However, many tumor types rely on angiogenesis for
growth, for which pericytes are critical, and so the inhibition of
pericyte-induced angiogenesis may also be a viable therapeutic
target to prevent tumor growth. This has been shown with
imatinib, which blocks the phosphorylation of PDGFR-β in
pericytes, preventing pericyte survival and proliferation, thus
reducing tumor growth (Ruan et al., 2013). Therefore, pericytes
appear to be a double-edged sword in cancer and any future
therapy options will require detailed understanding of their
biology and function in each individual cancer environment
(Meng et al., 2015).
CURRENT TECHNIQUES TO STUDY
PERICYTES
The current focus of pericyte research is to understand their
defining characteristics and roles in the healthy and diseased
brain. Pericytes can be distinguished from other mural cell
types by their morphology, location on the vasculature, and
expression profile (Armulik et al., 2011). Recently, a two-photon
imaging study of transgenic mice demonstrated the structural
diversity of cortical pericytes based on morphology, vascular
territory, and αSMA expression (Grant et al., 2019). Pericytes
are clearly heterogeneous and the specific role of each sub-class
in neurovascular function is currently unknown. New research
tools such as in vivo two-photon microscopy and single-cell RNA
sequencing as well as advancing transgenic mouse technology are
being applied to answer these questions and to better understand
the defining roles and characteristics of pericytes.
Single Cell Sequencing
Given their heterogeneity in structure and function, an important
future direction of pericyte research is the classification of
pericyte sub-classes. Sequencing technology has advanced rapidly
with researchers now examining the transcriptome, proteome,
metabolome, and secretome of cells. A recent study used single-
cell RNA sequencing to transcriptionally profile the principal
cell types of the brain vasculature (Vanlandewijck et al.,
2018). Results showed gradual arteriovenous transcriptional
zonation in EC, while no such zonation or subtyping was
seen within pericytes. Transmembrane transporter activity was
associated with genes that were overexpressed in brain pericytes
when compared with lung pericytes, providing evidence for
organotypic specialization of pericytes, and suggesting that
brain pericytes are directly involved in molecular transport
at the BBB. Though this technique has the potential to
identify pericyte subtypes, results of this particular study did
not find this same zonation profile within brain pericytes.
This hints that signaling from nearby cells may give rise to
the different pericyte morphology that is observed along the
arteriovenous axis.
Pericyte Immunochemistry
While pericytes were initially identified based on their distinct
cellular morphology, other techniques are available to identify
pericytes in vitro and ex vivo using immunochemistry.
Several antigen markers exist for pericytes including
PDGFR-β, neural/glial antigen 2 (NG2), α-SMA, desmin,
and aminopeptidase N (CD13), but all of these are also expressed
by other cells, such as oligodendrocyte precursor cells and
VSMC (Armulik et al., 2011). To confirm pericyte identity
through their juxtaposition with capillaries, pericyte markers
can be co-localized with vascular markers such as fluorescently
conjugated lectins (e.g., FITC-tomato lectin) or EC markers (e.g.,
CD31) (Robertson et al., 2015).
Pericytes in vitro
Pericytes possess the receptors and intracellular signaling
machinery to respond to neurotransmitters and vasoactive
mediators including noradrenaline, angiotensin-II, endothelin-
1, adenosine, and EC-derived nitric oxide (Hamilton et al.,
2010). In vitro pericyte preparations can be used to examine the
molecular biology and signaling pathways controlling pericyte
function. Primary pericyte cell culture using cells derived
from both human and rodent tissue has shown that pericytes
can contract and relax in response to vasoactive mediators
(Neuhaus et al., 2017), as well as secrete cytokines relevant to
neuroinflammatory responses (Rustenhoven et al., 2017). To
study how pericytes interact with other neurovascular cells,
specific in vitro models of the neurovasculature are being
developed. When human brain-derived pericytes and astrocytes
were cultured with human induced pluripotent stem cell-derived
EC, the cultures formed vascular networks in a fibrin gel (Campisi
et al., 2018). These co-cultures can be used to model the BBB and
examine interactions between cells as well as transportation and
diffusion dynamics of specific molecules. More recently, it was
shown that brain-specific mesoderm and neural crest pericyte-
like cells could be derived from human induced pluripotent stem
cells (Faal et al., 2019; Stebbins et al., 2019). This introduces the
possibility of culturing patient-specific pericytes, which would be
a valuable tool to study how genetic disease states affect pericyte
function. In combination, these techniques could enable the
generation of human patient-specific isogenic 3D microfluidic
systems, allowing the modeling of human neurovascular function
in specific disease states to help develop therapeutics with high
specificity (Stebbins et al., 2019). Another approach using ex vivo
brain slices with the cerebrovascular architecture intact can be
used to reveal molecular pathways that control pericyte functions
on capillaries (Hall et al., 2014; Mishra et al., 2016).
Pericytes in vivo
Transgenic mice are available with fluorescently labeled pericytes
(e.g., NG2-DsRed, PDGFR-β-tdTomato), and are commonly
used for imaging of pericytes in vivo using two-photon
microscopy (Hall et al., 2014; Hartmann et al., 2015). Pericyte
location on capillaries can be visualized using vascular tracers
such as FITC-dextran, but a disadvantage of both NG2- and
PDGFR-β reporters is that they label all mural cells which
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includes both pericytes and VSMC (Jung et al., 2017). Fluorescent
Nissl dye Neurotrace 500/525 has been shown to preferentially
bind to pericytes in vivo allowing the imaging of pericytes
without the need for transgenic animals (Damisah et al., 2017).
Mouse models of pericyte depletion have been developed (e.g.,
PDGFRβ+/−) which can lead to impaired BBB functionality
(Armulik et al., 2010). In addition, taking advantage of the Cre-
Lox systems, genes can specifically be knocked-in or -out within
pericytes to alter their function, for example LRP-1 (Ma et al.,
2018), but caution must be noted that other cell types depending
on the Cre-reporter line will also be affected (e.g., VSMC
and oligodendrocyte precursor cells). Optogenetic techniques,
in conjunction with 2-photon imaging, have been shown to
stimulate pericytes to generate a state of vessel constriction,
eliciting pericyte-driven capillary diameter changes (Kisler et al.,
2017a). However, this has not been consistent in all studies (Hill
et al., 2015), possibly due to differences in Cre drivers used or the
model and/or light source used.
FUTURE DIRECTIONS
Sub-Type Classification of Pericytes
In Hall et al. (2014), an important paper was published
stating that pericytes can regulate CBF. Controversially, the
next year a contradictory paper was published stating that
VSMC, not pericytes regulated CBF (Hill et al., 2015). This
disagreement appears to have arisen due to confusion about
the nomenclature of pericytes (Attwell et al., 2016) and has
revealed the need for a universal pericyte classification system.
Several researchers have shown, using high-resolution imaging
techniques, three distinct pericyte morphologies: ensheathing
pericytes which cover much of the vessel surface at the arteriole-
capillary junction and are thought to be contractile; mesh
pericytes on the capillary and post-capillary venule which
have short processes that are longitudinal and wrap around
the vessel; and finally, thin-strand pericytes in the middle
part of the capillary which display the traditional bump-on-a-
log morphology with thin processes running along the vessel
(Figure 1B; Attwell et al., 2016; Berthiaume et al., 2018).
However, while single-cell sequencing could be used to show
differential gene expression profiles of pericytes depending on
their location along the vascular tree, a recent study showed no
RNA expression changes within pericytes, and in fact pericytes
had a substantially different RNA expression profile to arteriolar
VSMC (Vanlandewijck et al., 2018).
Pericyte-Specific Drug Targeting
The ability to activate or inhibit pericyte function has enormous
potential to help treat the underlying cellular pathology in
disease. However, specific drug delivery to pericytes is difficult
considering pericytes share molecular pathways and surface
receptors with other cell types. In addition, drug delivery to
cerebral tissue is difficult, as the BBB allows only selective
passage of cells and small molecules. While strategies to overcome
this issue, such as viral vectors, exosomes, and nanoparticles,
have been trialed, their use to target pericytes in the brain
has been limited (Dong, 2018). One recent study demonstrated
successful peptide-conjugated nanoparticle delivery of the
anticancer drug docetaxel to peripheral pericytes in rats with
neuroblastoma (Guan et al., 2014), while peptide-conjugated
liposomal nanoparticles have also been used to effectively target
pericytes and deliver the anticancer drug doxorubicin in mice
with lung melanoma (Loi et al., 2010). Nanoparticle formulation
with pericyte-binding peptide sequences is possible (Kang and
Shin, 2016) but it has not yet been trialed in the brain. The
delivery of pericyte-targeted drugs through nanoparticles could
provide a novel therapeutic avenue for the treatment of many
neurovascular diseases.
Therapeutic Administration of Pericytes
Pericytes are essential to tissue repair processes; they direct
angiogenesis and therefore the supply of blood to repairing
tissue, as well as facilitate inflammatory responses and clear toxic
substances (Ribatti et al., 2011; Jansson et al., 2014; Rustenhoven
et al., 2017). It has been suggested that administration of
pericytes to brain regions where injury has occurred could
improve the repair process (Cheng et al., 2018). This concept
has recently been examined where the implantation of pericytes
into the brains of an AD mouse model improved blood flow
and reduced the magnitude of Aβ pathology (Tachibana et al.,
2018). The recent developments in induced human pluripotent
stem cell-derived pericytes provides the possibility to create
autologous pericyte cellular therapies for neurodegenerative
diseases that are specific to individual patients, averting
the possibility of complications such as immune rejection
of cells (Faal et al., 2019; Stebbins et al., 2019). Pericytes
themselves can also behave like stem cells and therefore may
be reprogrammed to differentiate into other neurovascular cells
such as neurons and EC (Nakagomi et al., 2015), which could
alleviate neurovascular dysfunction in disease. However, caution
over the administration method of pericytes, similar to stem
cell therapy, must be considered when contemplating pericyte
therapy for disease.
CONCLUSION
While it has been nearly 150 years since the first description
of pericytes, their functions in the brain, both in health and
disease, are still not fully understood. Pericytes form an integral
part of the NVU and act as a central mediator connecting
the brain parenchyma with the vascular system, in order to
meet the considerable metabolic demands of the brain. Pericytes
appear to be susceptible to injury and stress and it is now
recognized that pericyte degeneration can occur in multiple
neurological diseases. Recent advances in technology will enable
pericytologists to create a coordinated classification system for
pericyte sub-types and to determine how each of these influence
overall neurovascular function, in both the healthy and diseased
brain. Until recently, pericytes have been largely overlooked
in numerous areas of biology but their potential as either a
treatment or therapeutic target to alleviate neurological disease
is becoming recognized.
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KEY CONCEPTS
Pericyte
A multi-functional vascular cell that is embedded within the
capillary wall and is important in the regulation of CBF,
maintenance of the BBB, vascular development and stability, and
neuroinflammation. The dysfunction of pericytes in diseases such
as stroke and AD has recently been highlighted.
Neurovascular Unit (NVU)
A grouping of cells that regulate the interaction between the brain
parenchyma and the blood vessels supplying it. The NVU is made
up of neurons, astrocytes, microglia, pericytes, VSMC, and EC.
Blood-Brain Barrier (BBB)
A semi-permeable membrane separating the blood from
the cerebrospinal fluid, and constituting a barrier to the
passage of cells, particles, and large molecules. The BBB
is formed primarily by non-fenestrated endothelial cells
connected by tight junctions, and is supported by pericytes and
astrocyte endfeet.
Cerebral Blood Flow (CBF)
The flow of blood throughout the brain is vital for the
maintenance of brain function, as blood delivers the crucial
energy substrates oxygen and glucose required for neuronal
activity. CBF is tightly controlled at the molecular and cellular
levels by the NVU.
Neurological Disease
Diseases of the brain that can be caused by an acute
injury, e.g., stroke, or a chronic degenerative condition, e.g.,
Alzheimer’s disease.
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